ArticleCommunications medicine2026
A generalizable eye disease detection method based on Zero-Shot Learning.
Article in Communications medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDeep learning faces a significant bottleneck in medical image analysis due to its reliance on large-scale, expert-annotated datasets. This challenge is acute in ophthalmology, particularly for detecting early-stage diseases like mild Diabetic Retinopathy (DR1), where subtle lesions and a scarcity of annotations limit supervised learning approaches.
methodsWe propose a generalizable eye disease detection framework based on Zero-shot Learning (ZSL) that mimics clinical reasoning. Using the LCFP-14M dataset, a large-scale fundus image resource we present in this work, our method first identifies disease correlations via a Siamese network. It then transfers knowledge by segmenting DR1-specific lesions from a highly correlated source disease and employs a ResNet-Agglomerative clustering pipeline to enable unsupervised detection of DR1 without using any labeled DR1 cases.
resultsHere we show that the proposed framework enables effective DR1 detection without annotated DR1 data. The model achieves an accuracy of 0.8337, precision of 0.8700, recall of 0.7456, F1 score of 0.8030, and ROC-AUC of 0.9226, outperforming most supervised baselines on external test datasets.
conclusionsOur findings demonstrate that ZSL can simulate clinical diagnostic logic and generalize to unseen eye diseases, offering a promising approach for automated screening where labeled data are scarce.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.